
On 22 October 2026, the European Patent Office (EPO) Observatory on Patents and Technology released a benchmarking study revealing that 40.7% of European university-owned patents lapse within ten years due to critical funding and maintenance bottlenecks across Technology Transfer Offices (TTOs). Conducted with ASTP and Fraunhofer ISI across 809 European transfer offices, the investigation shows that while public research institutions drive over a third of European biotechnology and quantum patent filings, 90.5% of European TTOs operate on small or medium scales lacking the resources required to sustain academic inventions through commercialisation.
Pan-European Benchmark Maps University Patenting and Capacity Gaps
The report, titled Europe’s Technology Transfer Landscape: The Current State, Challenges and Avenues for Development of Technology Transfer Offices (DOI 10.65216/20261022-0001), represents the first Europe-wide empirical benchmark of academic knowledge commercialisation. Published by the EPO with the Fraunhofer Institute for Systems and Innovation Research (ISI) and ASTP, the study combines patent data with survey evidence from 809 European TTOs and interviews with 22 senior practitioners.
According to the official European Patent Office study release, European universities and public research organisations (PROs) more than doubled their patent output over two decades, growing from 3,200 filings in 2006 to nearly 8,000 in 2025. Academic patents now represent 9% of all European patent applications, matching the proportion seen in the United States. Furthermore, direct university patent ownership climbed to 53% in 2020 following the legislative abolition of the “professor’s privilege” across continental Europe.
However, post-filing patent maintenance reveals a severe retention deficit. Within ten years of filing, 40.7% of patents directly owned by European universities lapse due to maintenance costs and commercialisation hurdles, compared to just 26.3% of US university patents. While European institutions have closed the gap in generating initial patent assets, resource-constrained offices struggle to finance portfolio maintenance before licensing agreements or commercial partnerships can be finalized.
Key Details: Operational Disparities Between Large and Small TTOs
A primary finding is the stark structural imbalance across the European technology transfer landscape. Of the 809 TTOs surveyed, 90.5% (732 offices) are small or mid-sized operations, while only 9.5% (77 offices) operate at large scale. The operational differences between these tiers are substantial across every dimension:
| Metric and Dimension | Small & Mid-Scale TTOs (90.5%) | Large-Scale TTOs (9.5%) | Observed Operational Disparity |
|---|---|---|---|
| Average Staff Headcount | 1.0x baseline (3–7 FTEs) | 6.0x staffing level (25+ FTEs) | Large offices deploy 6x more staff |
| Supported Research Spend | 1.0x institutional base | 23.0x research expenditure | Large offices serve 23x greater funding |
| Supported Research Workforce | 1.0x researcher base | 6.8x research workforce size | Large offices support ~7x more scientists |
| Invention Disclosures | 1.0x baseline disclosure rate | 15.8x disclosure volume | Nearly 16x higher disclosure intake |
| Conversion Efficiency | Comparable per active disclosure | Comparable per active disclosure | Equivalent progress once admitted to pipeline |
| Specialist Infrastructure | Generalist teams, outsourced IP | In-house legal, valuation, VC desks | Large offices sustain specialist units |
| 10-Year Patent Lapse Rate | High lapses from budget exhaustion | Lower lapses via partner co-funding | Pan-European academic lapse reaches 40.7% |
The report emphasizes that the gap reflects capacity rather than individual competence: once an invention is admitted into the pipeline, small offices progress cases to patents, licences, and spin-offs at rates comparable to large offices. Econometric analysis of 256 reporting offices showed that doubling TTO staff is associated with 53% more startups, 43% more new ventures, 36% more spin-offs, and 21% more licences, options, and assignments. Without adequate staff, smaller teams lack the bandwidth to master how tech transfer offices evaluate and price a license or scout promising lab disclosures.
Public Research Anchors European Deep Tech and Strategic Sovereignty
Public research institutions serve as vital anchors of European technological sovereignty. In 2025, universities, PROs, and research hospitals accounted for 34% of European-origin patent applications in biotechnology, 29% in quantum technologies, and 26% in pharmaceuticals. Leading European academic filers include CNRS, the Fraunhofer-Gesellschaft, CEA, Inserm, and imec.
While Germany, France, and the UK previously accounted for 64% of academic patenting, their share shifted to 55% as countries like Spain, the Netherlands, and Belgium expanded their academic commercialisation ecosystems. Yet cross-border scaling remains difficult. As highlighted in ASTP knowledge transfer analysis, local TTOs rarely possess cross-border transactional reach. Although the Unified Patent Court and Unitary Patent has simplified multi-state validation, small offices still encounter barriers in multi-jurisdiction deal structures.
Sector Reaction Highlights Scale-Up Bottlenecks and Cross-Border Needs
European patent and university leaders stressed that technology transfer is fundamentally a matter of industrial competitiveness. António Campinos, President of the European Patent Office, commented: “Technology transfer is a competitiveness issue. Europe’s universities and public research organisations are at the forefront of scientific discovery, but breakthroughs must move from the lab to the market if they are to create jobs, growth and strategic autonomy. This means strengthening technology transfer, improving access to finance and building a more integrated single market for innovation. The study presented today identifies six priorities to help Europe turn research excellence into market success.”
Independent analysis by Laboratory News reporting on European TTO capacity emphasized that scaling spin-outs remains Europe’s hardest challenge: of 723 patent-active UK spin-outs tracked in the EPO Deep Tech Finder, 56% remain in early stages, with only 48 achieving valuations above £377 million. Further commentary from ERA Portal Austria on tech transfer gaps and the Austrian Patent Office on laboratory-to-market transition stressed that smaller TTOs need pooled regional infrastructure. Meanwhile, the League of European Research Universities innovation assessment called for sustained proof-of-concept financing to bridge the translational gap.
Implications for Researchers, Universities, and Research Offices
For universities and research offices, the 40.7% ten-year lapse rate demands a fundamental shift in portfolio strategy. Because patent renewal costs escalate sharply over time, research offices must actively budget for accumulating patent annuities and maintenance fees. Without dedicated maintenance funds, institutions routinely abandon promising patents during years 4 to 8—just as commercial prototypes mature.
To overcome structural capacity constraints, university leaders and research administrators are pursuing several concrete interventions:
- Decoupling Local Scouting from Shared Specialisation: Maintaining local presence for researcher engagement while pooling complex patent prosecution, valuation, and investor matching across regional consortia.
- Establishing Proof-of-Concept Bridge Funds: Internal validation grants allow inventors to de-risk inventions and demonstrate commercial feasibility before committing to expensive national phase patent entries.
- Reforming Academic Career Incentives: Aligning faculty promotion criteria to reward invention disclosures and licensing milestones alongside traditional journal publication metrics.
- Standardising Spin-Out Governance: Adopting uniform term sheets and licensing protocols to streamline the end-to-end technology transfer process across institutions.
- Harmonising Professional Definitions: Adopting recognized frameworks for technology transfer terminology to align institutional metrics with Horizon Europe valorisation standards.
Next Steps: Digital Platforms and Policy Rollouts
Alongside the study, the EPO launched two digital resources to support knowledge commercialisation. The new Data Desk dashboard provides granular visibility into public research patenting across 39 member states, capturing all co-applicants rather than only the primary applicant to illuminate collaborative industry partnerships. In addition, the EPO expanded its Deep Tech Finder platform to cover over 20,000 patent-active startups, 4,200 university spin-outs, 900 research organisations, and 15,000 investors across Europe.
European policymakers, the European Commission, and member state patent offices are now reviewing the report’s six strategic priorities. As international competitors—notably China under its 15th Five-Year Plan—expand state-backed technology commercialisation programs, European institutions face mounting pressure to establish sustainable funding for university technology transfer infrastructure.
Sources
- European Patent Office: Europe’s research breakthroughs face a technology transfer bottleneck, checked 2026-11-22
- ASTP: From public research to market success: Europe’s TT challenge, checked 2026-11-22
- Laboratory News: European technology transfer offices face capacity challenge, study finds, checked 2026-11-22
- ERA Portal Austria: Study reveals strengths and gaps in Europe’s technology transfer, checked 2026-11-22
- Austrian Patent Office: From Lab to Market: Study on the Role of Technology Transfer Offices in Europe, checked 2026-11-22
- League of European Research Universities: LERU universities among Europe’s leading innovators, new EPO data shows, checked 2026-11-22







